Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This trial iss conducted in Europe. The aim of this clinical trial is to evaluate the
hypoglycaemic response (the response to low blood sugar) to NN1250 (insulin degludec) in
subjects with type 1 diabetes.
The trial is designed as a two-period, crossover trial where the trial participant is
randomised to one of two treatment periods.